[1] |
Qiu H, Cao S, Xu R.Cancer incidence,mortality,and burden in China:a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020[J]. Cancer Commun (Lond), 2021, 41(10):1037-1048.DOI: 10.1002/cac2.12197.
|
[2] |
Kitahara CM, Sosa JA.The changing incidence of thyroid cancer[J]. Nat Rev Endocrinol, 2016, 12(11):646-653.DOI: 10.1038/nrendo.2016.110.
|
[3] |
Hoang JK, Lee WK, Lee M,et al.US Features of thyroid malignancy:pearls and pitfalls[J]. Radiographics, 2007, 27(3):847-865.DOI: 10.1148/rg.273065038.
|
[4] |
Scoazec JY, Couvelard A, Réseau TENpath. Classification of pancreatic neuroendocrine tumours:changes made in the 2017 WHO classification of tumours of endocrine organs and perspectives for the future[J]. Ann Pathol, 2017, 37(6):444-456.DOI: 10.1016/j.annpat.2017.10.003.
|
[5] |
Grani G, Lamartina L, Durante C,et al.Follicular thyroid cancer and Hürthle cell carcinoma:challenges in diagnosis,treatment,and clinical management[J]. Lancet Diabetes Endocrinol, 2018, 6(6):500-514.DOI: 10.1016/S2213-8587(17)30325-X.
|
[6] |
Itoh A, Ueno E, Tohno E,et al.Breast disease:clinical application of US elastography for diagnosis[J]. Radiology, 2006, 239(2):341-350.DOI: 10.1148/radiol.2391041676.
|
[7] |
Zhou J, Yin L, Wei X,et al.2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules:the C-TIRADS[J]. Endocrine, 2020, 70(2):256-279.DOI: 10.1007/s12020-020-02441-y.
|
[8] |
Durante C, Grani G, Lamartina L,et al.The diagnosis and management of thyroid nodules:a review[J]. JAMA, 2018, 319(9):914-924.DOI: 10.1001/jama.2018.0898.
|
[9] |
Choi SH, Kim EK, Kim SJ,et al.Thyroid ultrasonography:pitfalls and techniques[J]. Korean J Radiol, 2014, 15(2):267-276.DOI: 10.3348/kjr.2014.15.2.267.
|
[10] |
Lin Y, Lai S, Wang P,et al.Performance of current ultrasound-based malignancy risk stratification systems for thyroid nodules in patients with follicular neoplasms[J]. Eur Radiol, 2022, 32(6):3617-3630.DOI: 10.1007/s00330-021-08450-3.
|
[11] |
Jin M, Kim ES, Kim BH,et al.Clinical implication of world health organization classification in patients with follicular thyroid carcinoma in south korea:a multicenter cohort study[J]. Endocrinol Metab (Seoul), 2020, 35(3):618-627.DOI: 10.3803/EnM.2020.742.
|
[12] |
Tessler FN, Middleton WD, Grant EG.Thyroid imaging reporting and data system (TI-RADS):a user's guide[J]. Radiology, 2018, 287(1):29-36.DOI: 10.1148/radiol.2017171240.
|
[13] |
Daniels GH.Follicular thyroid carcinoma:a perspective[J]. Thyroid, 2018, 28(10):1229-1242.DOI: 10.1089/thy.2018.0306.
|
[14] |
|
[15] |
Sillery JC, Reading CC, Charboneau JW,et al.Thyroid follicular carcinoma:sonographic features of 50 cases[J]. AJR Am J Roentgenol, 2010, 194(1):44-54.DOI: 10.2214/AJR.09.3195.
|
[16] |
周树钧.甲状腺滤泡状癌的超声、临床病理特征及预后分析[D].福州:福建医科大学,2015.
|
[17] |
Hahn SY, Shin JH, Ko EY,et al.Complementary role of elastography using carotid artery pulsation in the ultrasonographic assessment of thyroid nodules:a prospective study[J]. Korean J Radiol, 2018, 19(5):992-999.DOI: 10.3348/kjr.2018.19.5.992.
|
[18] |
Borowczyk M, Woliński K, Wiᶒckowska B, et al. Sonographic features differentiating follicular thyroid cancer from follicular adenoma-a meta-analysis[J]. Cancers (Basel), 2021, 13(5):938.DOI: 10.3390/cancers13050938.
|
[19] |
Nikiforov YE.Molecular diagnostics of thyroid tumors[J]. Arch Pathol Lab Med, 2011, 135(5):569-577.DOI: 10.5858/2010-0664-RAIR.1.
|
[20] |
Kakarmath S, Heller HT, Alexander CA,et al.Clinical,sonographic,and pathological characteristics of RAS-positive versus BRAF-positive thyroid carcinoma[J]. J Clin Endocrinol Metab, 2016, 101(12):4938-4944.DOI: 10.1210/jc.2016-2620.
|
[21] |
段焕利.甲状腺肿瘤基因变异及其与临床病理特征、预后相关性的研究[D].北京:协和医学院,2019.
|
[22] |
Pennelli G, Vianello F, Barollo S,et al.BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma[J]. Thyroid, 2011, 21(12):1393-1396.DOI: 10.1089/thy.2011.0120.
|
[23] |
Kim TH, Kim YE, Ahn S,et al.TERT promoter mutations and long-term survival in patients with thyroid cancer[J]. Endocr Relat Cancer, 2016, 23(10):813-823.DOI: 10.1530/ERC-16-0219.
|
[24] |
Proietti A, Sartori C, Macerola E,et al.Low frequency of TERT promoter mutations in a series of well-differentiated follicular-patterned thyroid neoplasms[J]. Virchows Arch, 2017, 471(6):769-773.DOI: 10.1007/s00428-017-2236-6.
|
[25] |
Park H, Shin H C, Yang H,et al.Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations[J]. Mod Pathol, 2022, 35(2):186-192.DOI: 10.1038/s41379-021-00907-6.
|
[26] |
沙春艳.CK19,PCNA,VEGF,TTF-1在甲状腺滤泡性肿瘤中的表达及其意义[D].长春:吉林大学,2008.
|